Agreement between radiofrequency echographic multispectrometry and dual-energy X-ray absorptiometry for assessing bone mineral density in older patients during the acute phase following hip fracture.
Oct 2026· Osteoporosis International· 0 citations· 13 references
Medicine
TL;DR
REMS demonstrated moderate correlation but limited absolute agreement with DXA, and may be useful as a complementary tool after a hip fracture, but its values should not be considered directly interchangeable with DXA.
Background: Radiofrequency Echographic Multi-Spectrometry (REMS) is an ultrasound-based technique for the assessment of bone mineral density (BMD) that has been proposed as an alternative to dual-energy X ray absorptiometry (DXA) for the diagnosis of osteoporosis. Although previous studies have reported high diagnostic...
I. Nardone, Sium Wolde Sellasie, S. Zaccaria et al.· Diagnostics· 0 citations
BACKGROUND AND AIMS
Accurate body composition assessment is increasingly recognized as an important component of clinical nutrition assessment in obesity care; however, access to dual-energy X-ray absorptiometry (DXA) remains limited. Portable alternatives such as bioimpedance spectroscopy (BIS) and ultrasound may impr...
Louise Becroft, S. King, Lauren Hanna et al.· Clinical Nutrition ESPEN· 0 citations
The present results are not sufficiently precise or statistically robust to validate the method for BMD monitoring unequivocally in Russia, but they provide a basis for further research.
N. Sharashkina, Dmitrii Vladimirovich Rodionov, N. Runikhina et al.· Frontiers in Endocrinology· 0 citations
Background and Objectives: To evaluate whether skeletal muscle mass and handgrip strength are associated with early postoperative physical performance, assessed using the Short Physical Performance Battery (SPPB) approximately 6 weeks after surgery, in older adults after hip fracture surgery. Materials and Methods: Thi...
Cho E. Sim, Byung Hak Oh, H. Yoo et al.· Medicina· 0 citations
BHI should be regarded as a complementary tool rather than serving as a direct surrogate for DXA, as it highlights that BHI and DXA BMD assess distinct bone properties that are differentially influenced by systemic treatment like glucocorticoids.
J. Tung, Pakanut Pitupan, S. W. Poon et al.· Annals of Pediatric Endocrin...· 0 citations
This novel bedside DXA possesses reliable diagnostic performance for osteoporosis when evaluated against an independent composite reference standard, and is promising for screening immobile inpatients, though peripheral-site measurements cannot fully replace WHO-standard central axial DXA assessment.
Ming-Ran Luo, Run-Jia Liang, Xiao-Sheng Wang et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
